Rallybio Stock Quote RLYB - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.31

Bid

1.31

Ask

1.32

Volume

51,874

1.29 Day's Range 1.33

1.155 52 Week Range 6.38

Market Cap

53.884M

Previous Close

1.30

Open

1.31

Last Trade

1.31

Last Trade Time

14:18:36

Financial Volume

$ 67,731

VWAP

1.3057

Average Volume (3m)

232,137

Shares Outstanding

41,449,297

Dividend Yield

PE Ratio

-0.73

Earnings Per Share (EPS)

-1.8

Revenue

Net Profit

-74.56M

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.rallybio.com.

Headquarters

Wilmington, Delaware, USA

Founded

1970

Rallybio Holdings LLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was $1.30. Over the last year, Rallybio shares have traded in a share price range of $ 1.155 to $ 6.38.

Rallybio currently has 41,449,297 shares outstanding. The market capitalization of Rallybio is $53.88 million. Rallybio has a price to earnings ratio (PE ratio) of -0.73.

Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today...

Rallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations

– First Reported Large-Scale Analysis of FNAIT Risk Across Broad Population of Diverse Ancestries – – Topline Results Suggest a Significant Increase in the Number of Pregnancies at Higher Risk...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.08	-5.75539568345	1.39	1.42	1.155	258984	1.23289998	CS
4	-0.18	-12.0805369128	1.49	1.7291	1.155	212688	1.41445847	CS
12	-0.56	-29.9465240642	1.87	2	1.155	232137	1.64056035	CS
26	-0.79	-37.619047619	2.1	3.46	1.155	927667	2.60585862	CS
52	-3.92	-74.9521988528	5.23	6.38	1.155	497678	2.66257584	CS
156	-13.61	-91.2198391421	14.92	25.78	1.155	230762	4.64318464	CS
260	-13.61	-91.2198391421	14.92	25.78	1.155	230762	4.64318464	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SNGXSoligenix Inc	$ 8.03 (301.50%)	122.79M
ATNF180 Life Sciences Corporation	$ 3.25 (100.62%)	29.09M
PEGYPineapple Energy Inc	$ 2.1892 (82.43%)	58.68M
QUREuniQure NV	$ 6.3099 (66.93%)	44.96M
NBSTWNewbury Street Acquisition Corporation	$ 0.06 (50.38%)	31.17k
INDVIndivior PLC	$ 10.32 (-32.72%)	2.42M
CLEUChina Liberal Education Holdings Ltd	$ 0.3849 (-32.57%)	8.63M
NVOSNovo Integrated Sciences Inc	$ 0.518999 (-31.26%)	1.37M
HELEHelen of Troy Ltd	$ 65.00 (-26.97%)	4.38M
TRNRInteractive Strength Inc	$ 0.95 (-25.78%)	15.05M
NVDANVIDIA Corporation	$ 130.1523 (1.52%)	217.67M
MAXNMaxeon Solar Technologies Ltd	$ 0.2484 (-8.00%)	181.55M
TSLATesla Inc	$ 264.1086 (4.42%)	124.06M
SNGXSoligenix Inc	$ 8.03 (301.50%)	122.79M
SQQQProShares UltraPro Short QQQ	$ 7.4199 (0.27%)	81.43M